Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Overall, 58 percent discontinued before seeing any clinical benefit at all
Fischkoff, Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials
Nature 546(7657):248253
5-minute readPublished 05/15/2026Updated 11:10 AM EST, 06/08/2026 Managing your weight can get harder as you age
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy volunteers: a dose-escalation phase I study
US$ 21.79
US$ 22.88
US$ 23.66
US$ 26.10
